Hearing disorders: a high unmet medical need with a significant impact in young people

Sep 30, 2021

Posted by Cilcare

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1/2 Study of TP-0184 for the Treatment of Anemia in Patients with Low or Intermediate Risk Myelodysplastic Syndromes

Sep 28, 2021

Posted by Sumitomo Pharma Oncology, Inc.

David Dykeman Featured on Product Success Podcast: Quality and Medical Devices

Sep 28, 2021

Posted by Greenberg Traurig, LLP

Three Veterans of FDA’s Office of Chief Counsel, Jim Johnson, Scott Kaplan, and Chris Fanelli Join Sidley’s Global Healthcare and FDA Practice

Sep 28, 2021

Sidley Given Quintet of Awards by LMG Life Sciences Americas

Sep 24, 2021

eClinical Solutions to Spotlight Technology-Enabled Digital Transformation Strategies at 2021 Industry Conferences

Sep 21, 2021

Sidley Represents Underwriters in Upsized Tyra Biosciences IPO

Sep 20, 2021

SalioGen Therapeutics Strengthens Management with Key Additions to Leadership Team to Advance Its Gene Coding Platform

Sep 16, 2021